Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › DNTH
DEERFIELD MANAGEMENT COMPANY, L.P. position in DNTH
DIANTHUS THERAPEUTICS INC COM · Health Care
DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 1,125,313 shares of DNTH (DIANTHUS THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$109.7M, representing 1.38% of its reported portfolio and ranking #20 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed DNTH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DEERFIELD MANAGEMENT COMPANY, L.P.'s DNTH position evolved
DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in DNTH in Q1 2026 at 1,019,813 shares (US$85.6M). The position peaked in Q2 2026 at 1,125,313 shares, worth US$109.7M. Across 2 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,125,313 shares valued at US$109.7M — an increase of 105,500 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.02M | $85.58M | New |
| Q2 2026 | 1.13M | $109.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DNTH and 13F data
DNTH (DIANTHUS THERAPEUTICS INC COM) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DNTH
- Fairmount Funds Management LLC 2.54M sh · $247.33M · Q2 2026
- Avidity Partners Management LP 2.10M sh · $205.12M · Q2 2026
- Octagon Capital Advisors LP 1.84M sh · $179.53M · Q2 2026
- TCG Crossover Management, LLC 1.68M sh · $163.44M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 1.30M sh · $126.97M · Q2 2026
- Venrock Adviser, LLC 1.18M sh · $115.03M · Q2 2026
- BAKER BROS. ADVISORS LP 852.16K sh · $83.07M · Q2 2026
- Logos Global Management LP 800.00K sh · $77.98M · Q2 2026
- Cormorant Asset Management, LP 750.00K sh · $73.11M · Q2 2026
- BRAIDWELL LP 594.56K sh · $57.96M · Q2 2026
- MPM BioImpact LLC 420.00K sh · $40.94M · Q2 2026
- Affinity Asset Advisors, LLC 400.00K sh · $38.99M · Q2 2026
More on DEERFIELD MANAGEMENT COMPANY, L.P.
FAQ
How long has DEERFIELD MANAGEMENT COMPANY, L.P. held DNTH?
DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed DNTH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in DNTH?
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 1.13M shares of DNTH (DIANTHUS THERAPEUTICS INC COM), valued at $109.70M, representing 1.38% of its reported portfolio and ranking #20.
Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling DNTH?
In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. increased its position in DNTH. The position peaked in Q2 2026 at 1.13M shares.
Which other funds hold DNTH?
Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.